RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.
Clinical trial NCT02176122 · TERMINATED
Trial details
- NCT number
- NCT02176122
- Sponsor
- The University of Queensland
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2017-07-07
- Enrollment
- 391
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.